Heart Failure and Cardiac Transplantation Program
The Heart Failure Program integrates clinical care and heart failure research. Patients referred to the Heart Failure Program receive a full cardiac evaluation and optimization of their medical regimen including cardiac resynchronization devices. The heart failure evaluation customarily includes cardiopulmonary exercise testing and circulation assessment. Clinical research studies are currently studying new devices for monitoring and treating heart failure, as well as new drugs for the treatment of acute decompensated heart failure.
Patients with advanced heart failure are evaluated for cardiac transplantation or destination therapy with a left ventricular assist device (LVAD). More than twenty transplants and thirty LVAD implantations are performed each year.
The Pulmonary Hypertension Program evaluates and treats patients with primary and secondary forms of pulmonary hypertension. Treatmentsrange from oral vasodilating agents to continuous ambulatory infusions of pulmonary vasodilators, inhaled nitric oxide and investigational agents.
The Cardiovascular Medicine FPA is open from 8am until 6pm, Monday through Friday.